HBK Investments’s Zai Lab ZLAB Stock Holding History

HBK Investments’s Portfolio ZLAB Stock Details ZLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-50,000	Closed	-$1.35M	–	1160
2017 Q3	$1.35M	Buy	+50,000	New	+$1.39M	0.01%	548

Other funds holding ZLAB

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Myriad Asset Management North Point, Hong Kong $722M AUM 11.94% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

HBK Investments's ZLAB Position: Q4 2017 in Review

HBK Investments sold out of Zai Lab (ZLAB) in Q4 2017, closing a stake of 50,000 shares — an estimated $1.35M sold.

HBK Investments first reported a position in ZLAB in Q3 2017 and held it in 1 quarter. The position peaked at $1.35M in Q3 2017. 33 funds tracked by Wall St. Rank hold ZLAB as of Q4 2017.

HBK Investments reported no remaining Zai Lab position as of Q4 2017 after selling out during the quarter.
HBK Investments sold 50,000 Zai Lab shares in Q4 2017, an estimated $1.35M.
HBK Investments first reported a position in Zai Lab in Q3 2017 and held it in 1 quarter.
HBK Investments's Zai Lab position peaked at $1.35M in Q3 2017.
33 funds tracked by Wall St. Rank held Zai Lab as of Q4 2017.

Based on HBK Investments's 13F filing for Q4 2017, filed 14 Feb 2018.